Optimizing manufacturing protocols of chimeric antigen receptor T cells for improved anticancer immunotherapy
Chimeric antigen receptor (CAR) T cell therapy can achieve outstanding response rates in heavily pretreated patients with hematological malignancies. However, relapses occur and they limit the efficacy of this promising treatment approach. The cellular composition and immunophenotype of the administ...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
10 December 2019
|
| In: |
International journal of molecular sciences
Year: 2019, Jahrgang: 20, Heft: 24 |
| ISSN: | 1422-0067 |
| DOI: | 10.3390/ijms20246223 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.3390/ijms20246223 Verlag: https://www.mdpi.com/1422-0067/20/24/6223 
|
| Verfasserangaben: | Sophia Stock, Michael Schmitt and Leopold Sellner |
| Zusammenfassung: | Chimeric antigen receptor (CAR) T cell therapy can achieve outstanding response rates in heavily pretreated patients with hematological malignancies. However, relapses occur and they limit the efficacy of this promising treatment approach. The cellular composition and immunophenotype of the administered CART cells play a crucial role for therapeutic success. Less differentiated CART cells are associated with improved expansion, long-term in vivo persistence, and prolonged anti-tumor control. Furthermore, the ratio between CD4+ and CD8+ T cells has an effect on the anti-tumor activity of CART cells. The composition of the final cell product is not only influenced by the CART cell construct, but also by the culturing conditions during ex vivo T cell expansion. This includes different T cell activation strategies, cytokine supplementation, and specific pathway inhibition for the differentiation blockade. The optimal production process is not yet defined. In this review, we will discuss the use of different CART cell production strategies and the molecular background for the generation of improved CART cells in detail. |
|---|---|
| Beschreibung: | Gesehen am 17.02.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1422-0067 |
| DOI: | 10.3390/ijms20246223 |